< Back to previous page
Researcher
Karin Haustermans
- Disciplines:Radiation therapy, Cancer diagnosis, Cancer therapy, Cancer epidemiology
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Responsible
From1 Jan 2012 → Today - Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2005 → Today
Infrastructure
1 - 1 of 1
- The PaRtiCLE proton center. (Consortium coordinator)
Projects
1 - 10 of 40
- Outcome modeling in Proton TherapyFrom5 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards cost-effective patient selection for proton therapy in thoracic cancers: a framework for continuously updating prediction modelsFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Real-time qPCR platform enhancing research activities within the Laboratory of Experimental Oncology and the Laboratory of Experimental RadiotherapyFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Implementation, optimisation and evaluation of proton therapy in esophageal cancerFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Proton versus Photon Therapy for Esophageal Cancer - a Trimodality StrategyFrom1 Jul 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- The importance of the TNM Classification for Cancer Surveillance.From20 Oct 2020 → 30 Apr 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Accurate patient-individual prediction of proton therapy benefit in thoracic cancers using 3D dose maps and radiomicsFrom1 Oct 2020 → 30 Sep 2023Funding: FWO junior postdoctoral fellowship
- Characterization of the biological benefits of ultra-high dose rate FLASH proton therapy.From31 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Organ preserving strategies in rectal cancerFrom10 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization of overall treatment time for whole gland stereotactic body radiotherapy with integrated focal boosting in prostate cancerFrom6 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 365
- Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study(2022)
Authors: Lien Smets, Albert Wolthuis, Jeroen Dekervel, Christophe Deroose, Xavier Sagaert, Karin Haustermans
Pages: 113 - 120 - Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres(2022)
Authors: Gilles Defraene, Karin Haustermans
Pages: 32 - 41 - Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012(2022)
Authors: Cédric Draulans, Karin Haustermans
Pages: E147 - E148 - A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group(2022)
Authors: Karin Haustermans
Pages: 1 - 6 - Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis(2022)
Authors: Karin Haustermans
Pages: 254 - 269 - Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial(2022)
Authors: Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt
Pages: 127 - 132 - Current practice in proton therapy delivery in adult cancer patients across Europe(2022)
Authors: Karin Haustermans
Pages: 7 - 13 - Using ePROMs for follow-up after palliative radiotherapy: An exploratory study with patients and health care providers(2022)
Authors: Eva Oldenburger, Sofie Isebaert, Chantal Van Audenhove, Karin Haustermans
Pages: 2355 - 2361 - Using ePROMs for follow-up after palliative radiotherapy: An exploratory study with patients and health care providers(2022)
Authors: Eva Oldenburger, Sofie Isebaert, Chantal Van Audenhove, Karin Haustermans
Pages: 2355 - 2361 - Personalised radiation therapy taking both the tumour and patient into consideration(2022)
Authors: Karin Haustermans
Pages: A1 - A5